Mindray Cancer Antigen 125 (CA125) CLIA Reagent Kit

Mindray Cancer Antigen 125 (CA125) CLIA Reagent Kit is an in vitro diagnostic reagent designed for the quantitative determination of Cancer Antigen 125 in human serum or plasma using compatible Mindray CL-series automatic chemiluminescence immunoassay analyzers. CA125 is included in Mindray’s tumor-marker CLIA test menu. CA125 is a commonly measured tumor marker used in clinical laboratory evaluation and monitoring, particularly in relation to ovarian malignancies. Results should always be interpreted alongside clinical findings and other diagnostic information rather than used as a standalone cancer diagnosis. Key Features - Quantitative determination of Cancer Antigen 125 - Commonly identified as CA125 - Uses chemiluminescence immunoassay technology - Two-site sandwich immunoassay principle - Suitable for human serum or plasma - Compatible with Mindray CL-series CLIA analyzers - Liquid, ready-to-use reagent format - Available in 2 × 50 tests and 2 × 100 tests - Reportable range up to 5000 U/mL - Suitable for hospital, diagnostic and specialist laboratories - Intended for professional in vitro diagnostic use